Leili Darvish (L Darvish)
Publication Activity (10 Years)
Years Active: 2018-2019
Publications (10 Years): 2
Publications (10 Years): 2
Publications
- A Amraee, M R Evazi, M Shakeri, N Roozbeh, M Ghazanfarpour, M Ghorbani, J Ansari, Leili DarvishEfficacy of nivolumab as checkpoint inhibitor drug on survival rate of patients with relapsed/refractory classical Hodgkin lymphoma: a meta-analysis of prospective clinical study. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (8) (2019)